Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): A randomised, open-label, phase 3 trial
- Krop, I.E.
- Kim, S.-B.
- González-Martín, A.
- LoRusso, P.M.
- Ferrero, J.-M.
- Smitt, M.
- Yu, R.
- Leung, A.C.F.
- Wildiers, H.
ISSN: 1474-5488, 1470-2045
Argitalpen urtea: 2014
Alea: 15
Zenbakia: 7
Orrialdeak: 689-699
Mota: Artikulua